Data Collection and Sharing for Pathogen Surveillance : Making Sense of a Fragmented Global System
Copyright © 2024 RAND Corporation..
RAND Europe was commissioned by the Novo Nordisk Foundation to conduct a study on pathogen surveillance and current initiatives. The study aims to provide an overview of the pathogen surveillance space internationally and the stakeholders involved, as well as to understand the strengths and weaknesses of different initiatives, the challenges of pathogen surveillance and how they have been addressed, and how data has been used to inform public health decision making. To do this, a scoping review of pathogen surveillance initiatives was conducted, and ten case studies were developed and selected for further review following a workshop attended by the Novo Nordisk Foundation and RAND Europe study team. Interviews were conducted with individuals involved in pathogen surveillance initiatives to gather additional information to develop case studies, and expert interviews addressed gaps in the pathogen surveillance space and models that would be helpful in filling these gaps.
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:11 |
|---|---|
| Enthalten in: |
Rand health quarterly - 11(2024), 2 vom: 03. März, Seite 4 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Parkinson, Sarah [VerfasserIn] |
|---|
| Themen: |
Antimicrobial Resistance |
|---|
| Anmerkungen: |
Date Revised 11.04.2024 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
NLM370910427 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM370910427 | ||
| 003 | DE-627 | ||
| 005 | 20240411233343.0 | ||
| 007 | tu | ||
| 008 | 240411s2024 xx ||||| 00| ||eng c | ||
| 028 | 5 | 2 | |a pubmed24n1372.xml |
| 035 | |a (DE-627)NLM370910427 | ||
| 035 | |a (NLM)38601714 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Parkinson, Sarah |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Data Collection and Sharing for Pathogen Surveillance |b Making Sense of a Fragmented Global System |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 500 | |a Date Revised 11.04.2024 | ||
| 500 | |a published: Electronic-eCollection | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a Copyright © 2024 RAND Corporation. | ||
| 520 | |a RAND Europe was commissioned by the Novo Nordisk Foundation to conduct a study on pathogen surveillance and current initiatives. The study aims to provide an overview of the pathogen surveillance space internationally and the stakeholders involved, as well as to understand the strengths and weaknesses of different initiatives, the challenges of pathogen surveillance and how they have been addressed, and how data has been used to inform public health decision making. To do this, a scoping review of pathogen surveillance initiatives was conducted, and ten case studies were developed and selected for further review following a workshop attended by the Novo Nordisk Foundation and RAND Europe study team. Interviews were conducted with individuals involved in pathogen surveillance initiatives to gather additional information to develop case studies, and expert interviews addressed gaps in the pathogen surveillance space and models that would be helpful in filling these gaps | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Antimicrobial Resistance | |
| 650 | 4 | |a Biosurveillance | |
| 650 | 4 | |a Coronavirus Disease 2019 (COVID-19) | |
| 650 | 4 | |a Data Analysis | |
| 650 | 4 | |a Global Health | |
| 650 | 4 | |a Influenza | |
| 650 | 4 | |a Pandemic | |
| 700 | 1 | |a Dawney, Jessica |e verfasserin |4 aut | |
| 700 | 1 | |a Adams, Avery |e verfasserin |4 aut | |
| 700 | 1 | |a Senator, Ben |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Rand health quarterly |d 2011 |g 11(2024), 2 vom: 03. März, Seite 4 |w (DE-627)NLM267957521 |x 2162-8254 |7 nnns |
| 773 | 1 | 8 | |g volume:11 |g year:2024 |g number:2 |g day:03 |g month:03 |g pages:4 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 11 |j 2024 |e 2 |b 03 |c 03 |h 4 | ||